Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

Jim Cramer’s Takes on These 17 S&P 500 Stocks

Page 1 of 16

Jim Cramer, host of Mad Money, reviewed the S&P 500’s strongest and weakest performers in February on Monday.

After an eventful weekend, it seems pretty clear that March is going to be very different from the month of February, but before we can focus on the new world where we’re exchanging rockets with Iran, I want to go over where we were coming from because February was a rough month for the market. While the Dow Jones Industrial Average rallied slightly, up 0.2%, the S&P dropped 0.9%, and the Nasdaq plunged 3.4%.

READ ALSO: Jim Cramer’s Game Plan: 11 Stocks in Focus This Week and Jim Cramer Put These 16 Stocks Under the Microscope.

Commenting on the 10 biggest decliners in the S&P 500, Cramer said that they tell two important stories. First, he said, enterprise software and professional services companies have been hammered by fears of AI displacement. He called those concerns “somewhat reasonable,” though he added that it is still too early to draw conclusions. Second, he pointed to increasing strain in private credit. He noted that it happened because many firms in that space were overly eager to extend loans to software companies. He went on to say that private credit has now become a separate issue that troubles him even more.

Here’s the bottom line: When you look at the S&P’s top 10 biggest winners from last month, you find a lot of data center suppliers, some energy stocks, a little aerospace, and one med tech play… When you look at the last month’s biggest losers, you see a lot of worries about AI displacement, something we talk about a lot, something that’s even spread to the private credit space, simply because many of these firms have a ton of exposure to the enterprise software cohort that we’re also worried about. Will the losers keep losing? I think March will be very different from February unless peace breaks out with Iran. But if you’re hoping for a rebound from last month’s hardest hit stocks, I think it’s kind of, a little bit of bounce here and then, don’t hold your breath.

Our Methodology

For this article, we compiled a list of 17 stocks that were discussed by Jim Cramer during the episode of Mad Money aired on March 2. We listed the stocks in the order that Cramer mentioned them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

Jim Cramer’s Takes on These 17 S&P 500 Stocks

17. IQVIA Holdings Inc. (NYSE:IQV)

IQVIA Holdings Inc. (NYSE:IQV) is one of the S&P 500 stocks that Jim Cramer shared his take on. Cramer called it a “great business,” as he said:

Finally, the ninth-worst performing stock in the S&P 500 was IQVIA, down 22.3%. Now, this is a CRO, a contract research organization. Pharmaceutical companies hire these guys to run their clinical trials. Oh, what a great business. The CROs were all caught up in the AI displacement trade, unfairly, in my opinion. I just don’t see that happening at all. When IQVIA reported in early February, although, the company reported a solid beat, but also gave a weaker than expected full-year forecast.

Now, I know it doesn’t help that RFK Junior’s FDA is taking a skeptical approach toward new drugs, particularly orphan drugs, by the way. Overall, with expectations now reset, I am tempted to say that you’re probably getting a nice buying opportunity here. But this is another company where any potential buyers will be swimming upstream. I like the business very much. I just don’t know whether this is the right stock to play it.

IQVIA Holdings Inc. (NYSE:IQV) provides clinical research and data analytics to the healthcare and life sciences industries. The company assists pharmaceutical and biotech companies by managing clinical trials, providing laboratory services, and tracking sales and patient engagement.

16. Fox Corporation (NASDAQ:FOX)

Fox Corporation (NASDAQ:FOX) is one of the S&P 500 stocks that Jim Cramer shared his take on. Cramer called the company being one of the worst-performing stocks in the S&P 500 an “anomaly.” He said:

Next up, the eighth-worst-performing in the S&P last month was Fox. Now, this is an anomaly. It’s down 22.6%. Odd. Fox has been the best-performing traditional media company for a while now and reported a stellar quarter in early February, just a colossal earnings beat. But the stock sold off in response, and it’s been sinking lower ever since. I think the sellers might be worried about new competition, as Paramount won the bidding war for Warner Brothers Discovery. Whatever the reason, Fox now trades at just 12 times this year’s earnings estimates, and I think that’s pretty cheap, too cheap.

Fox Corporation (NASDAQ:FOX) produces and distributes news, sports, and entertainment content and manages a studio lot for film and television production. We recently covered Bank of America’s recent downgrade and price revision on the stock. You can read it here.

Page 1 of 16

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

 

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.